Analyst Insight
Aridis Pharmaceuticals, Inc. (ARDS) Stock Showing Signs of Bearishness in Premarket, Here’s the Potential Reason
Aridis Pharmaceuticals, Inc. (ARDS), a late-stage biopharmaceutical company, has declined by 5% in premarket trading session and consequently is trading at $1.52 at the time
